Observational studyBMJ open2020

On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: a prospective cohort study from 2013 to 2017.

Christer Frode Aas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.